HAUPPAUGE, N.Y. and NEW YORK, March 05, 2018 -- Intelligent Product Solutions (IPS) today announced that the Cooper Hewitt, Smithsonian Design Museum in New York City selected the AdhereTech Smart Pill Bottle for its “Access +Ability” exhibit, on view from Dec. 15, 2017 - Sept. 3, 2018. IPS, a subsidiary of Forward Industries and a leading product design and development firm, partnered with AdhereTech to design and develop the “smart” pill bottle that reminds patients to take their medication.
The Cooper Hewitt exhibit “Access+Ability” features more than 70 works from adaptive clothing and eating implements that assist with daily routines to apps and “smart” technologies that aid in social interactions and navigating the environment. Among the 70 designs, the AdhereTech Smart Pill Bottle was included. To increase medication adherence, the AdhereTech pill bottle can send a text message (to a patient or caregiver), light up, or play a song if patients forget to take their medication. Many top pharmaceutical companies and specialty pharmacies and hospitals currently use AdhereTech and these innovative smart bottles improve medication adherence by an average of 20%.
Among its many recognitions, the AdhereTech Smart Pill Bottle received the 2017 A’ International Design Award in the Medical Product Design category. The A’ International Design Award is a prestigious recognition given to top designs worldwide that demonstrate an exemplary level of greatness in design. In 2016, the Smart Pill Bottle received the prestigious GOOD DESIGN Award, the world’s oldest prize dedicated to the most innovative and cutting-edge industrial products and graphic designs produced around the world.
The Cooper Hewitt is the only museum in the United States devoted exclusively to historic and contemporary design. It is located at 2 East 91st Street at Fifth Avenue in New York City.
About IPS
IPS, a subsidiary of Forward Industries (NASDAQ:FORD), is a leading product design and development company that is headquartered in New York, with an office in Minneapolis. IPS offers expert product design and engineering services, including Internet of Things and wearable technology solutions. IPS' fully-integrated capabilities include industrial design, electrical, mechanical and systems engineering, optical engineering, application level software and low level firmware engineering, user experience/interface design (UX/UI), program management and marketing. Its clients are among the leading brands in consumer electronics, medical devices, enterprise and security solution providers and Internet of Things connected solutions, including Google, Physio Control, Motorola and Charity Water. To learn more about IPS, visit www.intelligentproduct.solutions or contact [email protected] or @IPSdesigners.
For more information, contact:
Lisa Hendrickson
LCH Communications
516-767-8390
[email protected]


Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



